430 results were returned
International law firm Bird & Bird has advised health analytics start-up Biofourmis with the deployment of its AI-driven remote monitoring platform to observe patients in Hong Kong who are diagnosed with or suspected to ...
Bird & Bird are delighted to announce that our Asia IP team were named as winners at the ninth Asia IP Awards that recently took place in Taipei.
In the recent case of InterPharma Pty Ltd v Hospira Inc (No 5) [2019] FCA 960 the Australian Federal Court has given patentees guidance as to novelty preserving practice in the conduct of clinical trials.
The defendant, Ms Wai Hei Wong, was an employee at the plaintiff's store, Pet Line. Pet Line sought damages arising from negligence and/or breach of duty and also sought the return of bonus payments made to Ms Wong.
In this issue of Bird & Bird's APAC Frontline, we will look back at the significant changes that came into effect in the last quarter across Australia, Hong Kong, the People's Republic of China (PRC) and Singapore.
"Competition Laws in Asia Pacific: Highlights from 2018 and what's coming next in 2019". This comprehensive review of Competition Law across the region covers developments in various Asia Pacific countries.
Existing rights holders should collate and prepare the necessary documents and information for re-filing of all their marks during the Soft Opening in December 2019 / January 2020. Where there are amendments to the ...
DEFAULT DEFAULT Most Relevant Alphabetical Chronological Go
REFINE RESULTS: